Taysha Gene Therapies doses patient #2 and provides an update on their clinical trial plans in Canada, US and UK.

Taysha Gene Therapies reports on safety and efficacy results for the first patient to receive gene therapy for Rett Syndrome

On November 14, 2023 Taysha Gene Therapies provided an encouraging update on Patient #1 and #2. Please see links below for clinical updates and timelines for US and UK trials.

Letter to Patient Advocacy Leaders

Taysha Press Release

$40M

Take Action

Taysha Provides Update on Patient #1 and #2